480 related articles for article (PubMed ID: 18420945)
1. Ste20-related kinase SLK phosphorylates Ser188 of RhoA to induce vasodilation in response to angiotensin II Type 2 receptor activation.
Guilluy C; Rolli-Derkinderen M; Loufrani L; Bourgé A; Henrion D; Sabourin L; Loirand G; Pacaud P
Circ Res; 2008 May; 102(10):1265-74. PubMed ID: 18420945
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of serine 188 protects RhoA from ubiquitin/proteasome-mediated degradation in vascular smooth muscle cells.
Rolli-Derkinderen M; Sauzeau V; Boyer L; Lemichez E; Baron C; Henrion D; Loirand G; Pacaud P
Circ Res; 2005 Jun; 96(11):1152-60. PubMed ID: 15890975
[TBL] [Abstract][Full Text] [Related]
3. Angiotensin II up-regulates the leukemia-associated Rho guanine nucleotide exchange factor (RhoGEF), a regulator of G protein signaling domain-containing RhoGEF, in vascular smooth muscle cells.
Ying Z; Jin L; Palmer T; Webb RC
Mol Pharmacol; 2006 Mar; 69(3):932-40. PubMed ID: 16354763
[TBL] [Abstract][Full Text] [Related]
4. AT2 receptors cross talk with AT1 receptors through a nitric oxide- and RhoA-dependent mechanism resulting in decreased phospholipase D activity.
Andresen BT; Shome K; Jackson EK; Romero GG
Am J Physiol Renal Physiol; 2005 Apr; 288(4):F763-70. PubMed ID: 15572519
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptor gamma ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2.
Wakino S; Hayashi K; Kanda T; Tatematsu S; Homma K; Yoshioka K; Takamatsu I; Saruta T
Circ Res; 2004 Sep; 95(5):e45-55. PubMed ID: 15308580
[TBL] [Abstract][Full Text] [Related]
6. Signal-crosstalk between Rho/ROCK and c-Jun NH2-terminal kinase mediates migration of vascular smooth muscle cells stimulated by angiotensin II.
Ohtsu H; Mifune M; Frank GD; Saito S; Inagami T; Kim-Mitsuyama S; Takuwa Y; Sasaki T; Rothstein JD; Suzuki H; Nakashima H; Woolfolk EA; Motley ED; Eguchi S
Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1831-6. PubMed ID: 15994438
[TBL] [Abstract][Full Text] [Related]
7. Regulation of myosin light chain kinase expression by angiotensin II in hypertension.
Han YJ; Hu WY; Piano M; de Lanerolle P
Am J Hypertens; 2008 Aug; 21(8):860-5. PubMed ID: 18511912
[TBL] [Abstract][Full Text] [Related]
8. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways.
Montezano AC; Callera GE; Yogi A; He Y; Tostes RC; He G; Schiffrin EL; Touyz RM
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1511-8. PubMed ID: 18467645
[TBL] [Abstract][Full Text] [Related]
9. Defective RhoA/Rho-kinase signaling contributes to vascular hypocontractility and vasodilation in cirrhotic rats.
Hennenberg M; Biecker E; Trebicka J; Jochem K; Zhou Q; Schmidt M; Jakobs KH; Sauerbruch T; Heller J
Gastroenterology; 2006 Mar; 130(3):838-54. PubMed ID: 16530523
[TBL] [Abstract][Full Text] [Related]
10. cGMP-dependent protein kinase phosphorylates and inactivates RhoA.
Sawada N; Itoh H; Yamashita J; Doi K; Inoue M; Masatsugu K; Fukunaga Y; Sakaguchi S; Sone M; Yamahara K; Yurugi T; Nakao K
Biochem Biophys Res Commun; 2001 Jan; 280(3):798-805. PubMed ID: 11162591
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide-induced decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho kinase pathway.
Bolz SS; Vogel L; Sollinger D; Derwand R; de Wit C; Loirand G; Pohl U
Circulation; 2003 Jun; 107(24):3081-7. PubMed ID: 12796138
[TBL] [Abstract][Full Text] [Related]
12. Ca2+-dependent activation of Rho and Rho kinase in membrane depolarization-induced and receptor stimulation-induced vascular smooth muscle contraction.
Sakurada S; Takuwa N; Sugimoto N; Wang Y; Seto M; Sasaki Y; Takuwa Y
Circ Res; 2003 Sep; 93(6):548-56. PubMed ID: 12919947
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Rho proteins by phosphorylation in the cardiovascular system.
Loirand G; Guilluy C; Pacaud P
Trends Cardiovasc Med; 2006 Aug; 16(6):199-204. PubMed ID: 16839863
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II/AT2 receptor-induced vasodilation in stroke-prone spontaneously hypertensive rats involves nitric oxide and cGMP-dependent protein kinase.
Savoia C; Ebrahimian T; He Y; Gratton JP; Schiffrin EL; Touyz RM
J Hypertens; 2006 Dec; 24(12):2417-22. PubMed ID: 17082724
[TBL] [Abstract][Full Text] [Related]
15. Diguanosine pentaphosphate: an endogenous activator of Rho-kinase possibly involved in blood pressure regulation.
Tölle M; Giebing G; Tietge UJ; Jankowski J; Jankowski V; Henning L; Hörl MP; Weiss W; Zidek W; van der Giet M
J Hypertens; 2006 Oct; 24(10):1991-2000. PubMed ID: 16957559
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II stimulates serine phosphorylation of the adaptor protein Nck: physical association with the serine/threonine kinases Pak1 and casein kinase I.
Voisin L; Larose L; Meloche S
Biochem J; 1999 Jul; 341 ( Pt 1)(Pt 1):217-23. PubMed ID: 10377265
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of sustained smooth muscle contraction by PKA and PKG preferentially mediated by phosphorylation of RhoA.
Murthy KS; Zhou H; Grider JR; Makhlouf GM
Am J Physiol Gastrointest Liver Physiol; 2003 Jun; 284(6):G1006-16. PubMed ID: 12736149
[TBL] [Abstract][Full Text] [Related]
18. Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats.
Savoia C; Tabet F; Yao G; Schiffrin EL; Touyz RM
J Hypertens; 2005 May; 23(5):1037-45. PubMed ID: 15834290
[TBL] [Abstract][Full Text] [Related]
19. A role for Rho-kinase in Ca-independent contractions induced by phorbol-12,13-dibutyrate.
Baek I; Jeon SB; Kim J; Seok YM; Song MJ; Chae SC; Jun JE; Park WH; Kim IK
Clin Exp Pharmacol Physiol; 2009 Mar; 36(3):256-61. PubMed ID: 18986333
[TBL] [Abstract][Full Text] [Related]
20. BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder.
Morelli A; Vignozzi L; Filippi S; Vannelli GB; Ambrosini S; Mancina R; Crescioli C; Donati S; Fibbi B; Colli E; Adorini L; Maggi M
Prostate; 2007 Feb; 67(3):234-47. PubMed ID: 17163492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
